Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Safety Blood Collection Device Eliminates Needlestick Risk

By HospiMedica International staff writers
Posted on 05 May 2011
A new blood collection device is completely passive, automatically hiding the needle without the clinician having to perform any additional tasks.

The Vacuette Premium Tube-Touch safety-needle system blood collection device is designed with an integrated, multiple sample needle and safety shield safety mechanism that automatically activates through normal use, with no additional step by the user. More...
Insertion of the first blood collection tube causes the safety shield to be automatically released, which automatically covers the needle immediately following blood collection from the patient. The Tube-Touch is available in 20G, 21G, and 22G gauges.

Vacuette tube-activated blood collection devices employ a mode of action that impinges on the safety trigger, causing wing-like sheaths to deploy around the needle. Blood cannot be drawn unless the safety system has been engaged. If the vein is missed, the phlebotomist can reposition with the same device, provided a collection tube has not been inserted into the collection device. The Vacuette Premium Tube-Touch is a product of Greiner Bio-One (Kremsmünster, Austria), and has been approved by the US Food and Drug Administration (FDA).

"Greiner Bio-One introduced the first plastic evacuated blood collection tube on the market to provide phlebotomist, nurse, and laboratory professionals a new level of safety and product effectiveness that would help to eliminate the use of dangerous glass tubes,” said Franz Konrad, CEO of Greiner Bio-One. "We continue to provide a high level of service to the medical professional community in the products we bring to customers.”

Healthcare workers worldwide experience millions of needlestick injuries per year, and as many as two-thirds of these events go unreported; US hospitals report approximately 30 needlestick injuries per year for every 100 beds. Needlesticks have been responsible for infections from more than 20 different infectious agents, including human immunodeficiency virus (HIV), Hepatitis B virus (HBV), and Hepatitis C virus (HCV). The rate of infection following needlestick exposure has been calculated for HIV as 0.3%; figures for HCV and HBV have been reported as 1.7% and as high as 30%, respectively. While most needlestick injuries carry no adverse health consequences, the possibility of infection with life-threatening microbes exists, especially with exposure to body fluids.

Related Links:

Greiner Bio-One



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Syringes
Prefilled Saline Flush Syringes
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.